A cross-sectional serosurvey on hepatitis B vaccination uptake among adult patients from GP practices in a region of South-West Poland by Maria Ganczak et al.
RESEARCH ARTICLE Open Access
A cross-sectional serosurvey on hepatitis B
vaccination uptake among adult patients from
GP practices in a region of South-West Poland
Maria Ganczak1*, Gabriela Dmytrzyk-Daniłów2, Marcin Korzeń3 and Zbigniew Szych4
Abstract
Background: Hepatitis B is a significant health burden in Poland with nosocomial transmission being the main source
of infection. Therefore, HBV vaccination is widely recommended for those not covered by the national immunisation
program. Objective: To assess the coverage and influencing determinants of HBV vaccination among adult patients
attending GP clinics as well as to establish serological status in terms of HBV infection.
Methods: Patients who were seen consecutively in March 2013 at four randomly selected GP practices located in
Zgorzelec county, in south-western part of Poland, were invited to participate and complete questionnaires on
socio-demographic data and other factors related to vaccination. A pilot study was done in one urban GP practice in
the city of Gryfino (Gryfino county), the results have been included in the study. Patients’ immunisation status was
assessed basing on vaccination cards and anti-HBs titer with the use of third-generation testing methods. In addition,
serum samples were assayed for anti-HBc total.
Results: Response rate: 99.3 %. Of 410 participants (66.1 % females, median age 56 years), 55.4 % (95%CI:50.5-60.1 %)
were previously vaccinated; in those 11.5 % took 2 doses, 66.1 % - 3 doses,18.1 % – 4 doses. Elective surgery was the
main reason (57.7 %) for HBV immunization, 4.8 % - were vaccinated due to recommendations by GPs. The multivariable
logistic regression model revealed that living in a city (OR 2.11), and having a surgery in the past (OR 2.73) were each
associated with greater odds of being vaccinated. Anti-HBc total prevalence among those unvaccinated was 13.6 %
(95%CI:9.3 %-19,5 %), and 7.2 % (95%CI:4.4-11.8 %) among those vaccinated.
Conclusions: Low HBV immunization coverage among adult patients from GP clinics and the presence of serological
markers of HBV infection among both - those unvaccinated and vaccinated call for comprehensive preventative measures
against infection, including greater involvement of family doctors. Although interventions should cover the whole
population, inhabitants living in the rural areas should be a group of special interest. Preoperative immunization for HBV
seems to be an efficient public health tool to increase the vaccination uptake.
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Background
According to the most recent World Health Organization
estimate, two billion people worldwide have been infected
with hepatitis B virus (HBV), 240 million are chronically
infected, and approximately 780,000 persons die each year
from hepatitis B (HB) infection – 650,000 from cirrhosis
and liver cancer due to chronic HB infection and another
130,000 from acute HB [1, 2]. Although Poland is classi-
fied as a geographic region of low endemicity of the
prevalence of hepatitis B surface antigen (HBsAg), HB is
still a significant health burden. There are approximately
350,000-450,000 carriers (1.5 %) of HBsAg in the popula-
tion [3, 4].
In 1986 safe and effective DNA recombinant vaccines
became available, which are now one of the most widely
used worldwide [5]. In Poland, neonatal vaccination began
in 1989 with neonates born to HBsAg positive mothers.
From 1993 to 1995 it was gradually expanded to neonates
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from some selected regions with the highest incidence of
HBV infection; then, since 1996 it has covered all neo-
nates [6, 7]. Since that period, active immunisation is also
offered to recipients of blood and blood products, hemo-
dialysed patients, household members and sexual partners
of HBsAg carriers, as well as health care workers and
medical students [6, 7]. In 2000, universal vaccination of
adolescents of 14 years of age was introduced for those
not covered by neonatal vaccination [6].
Although HBV vaccination is clearly the most effective
strategy for preventing HB and the vaccine has been
available for almost 30 years, the extent to which such a
strategy is practiced or how the society follows it at the
primary care level have not been precisely evaluated not
only in Poland, but also in many other European Union
(EU) countries. None of the EU countries surveyed in
the VENICE project between 2010 and 2011 was able to
provide coverage estimates for HBV adult vaccine [8].
According to data from the 1970s to 1990s, about
60 % of HB adult cases in Poland were acquired as a re-
sult of hospitalization or medical procedures provided in
other health care facilities [8]. Therefore, between 1993
and 1997, active immunization against HB with two
doses of a vaccine was required from all elective surgery
patients to reduce the number of infections generated
nosocomially. It has been estimated that 681,000 pa-
tients were vaccinated in 1997 due to this regulation [9].
The immunization requirement for preoperative HBV
vaccination no longer applies due to slow but steady im-
provements in aseptic conditions (e.g. in 1994 in Poland,
there were 5000 autoclaves in hospitals and 60,000 dry
heat sterilizers, i.e. a ratio of 1:12, by the end of 1997 it
had fallen to 1:7.7, since the end of 2009 dry heat steril-
izers are no longer used) [6] as well as an increase in
disposable medical devices use. Another reason was a
national discussion where the opponents argued that the
preoperative HBV vaccination policy might be a stimulus
for health care facilities to neglect infection control pro-
cedures [9].
However, currently, a preoperative immunisation for
HBV is still recommended by the National Immunisa-
tion Program [10] and an immunisation certificate is un-
officially required for elective surgical procedures in
some health care facilities. Our previous study revealed
that such a policy influenced the very high immunisation
coverage (82 %) among surgical patients admitted for
elective procedures [11]. However, it has not been assessed
so far to which extent patients who were operated on after
taking two doses of a HBV vaccine complete the 3-dose
course in a relevant time.
Objectives
The objective of the study was to assess the HBV vaccin-
ation uptake among adult patients from GP practices, to
define the reasons for immunization, the contributing
factors as well as to evaluate the prevalence of sero-
logical markers of HBV infection among this population.
Methods
Design & setting
A cross-sectional sero-epidemiological survey was con-
ducted in March 2013 among patients presented at ran-
domly selected GP practices from the county of
Zgorzelec, Poland. Patients 27 years old and more were
invited to participate, due to the fact that in Poland the
universal vaccination of adolescents of 14 years of age
was introduced in 2000 for those not covered by neo-
natal vaccination. Therefore, in 2013, when the partici-
pants of this study were recruited, the adult population
less than 27 years of age was protected against HBV in-
fection through universal immunization.
Study population & sampling
The sampling frame included a list of GP clinics in the
Zgorzelec county obtained from the local health depart-
ment. All GP practices in the region were stratified into
urban and rural, to ensure representation of different
practice levels. Random selection of 3 urban practices and
1 rural practice was done, proportionally to the number of
patients covered by each type of practice. A pilot study
was done in one urban GP practice in the city of Gryfino
(Gryfino county) on 107 patients [12], the results have
been included in the study. The authors’ choice regarding
the relatively numerous group of patients involved in the
pilot study was due to the fact that it was the first sero-
survey conducted in Poland which queried GP clinic pa-
tients on their vaccination status not only with the help of
questionnaires, but also by obtaining their blood samples.
Therefore, the authors’ intention was to check various
possible technical problems connected with blood sample
collection and management (i.e. connected with question-
naire administration in relation to blood collection, a per-
son responsible for blood collection, the delivery of blood
samples to the lab etc.), as well as conducting the study in
a timely manner. The anonymity of the subjects was pre-
served by a code given to the patient, for the questionnaire
and for the blood sample. At each facility blood samples
were obtained from all eligible patients who gave informed
written consent to participate.
Study instrument
A questionnaire administered by one of the researchers
(G.D-D.) included questions that queried patients on the
following:
demographic including age, gender, residency,
literacy, socio-economic status, employment status
facility location
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history of HBV vaccination
reasons for HBV vaccination
In addition, knowledge about HBV infection was assessed
by 22 questions grouped in 4 categories: natural history of
HBV, transmission routes, immunization, treatment. The
overall score for each respondent was calculated, with the
maximum score 22 and minimum 0 points.
Sero-testing
HBV immunization status was based on the results of
vaccination cards and by the enzyme immunoassay for
the quantitative detection of antibodies to the surface
antigen of HBV (anti-HBs). Qualitative detection of total
antibodies to the core antigen (anti-HBc total) was used
(Hoffman-La Roche Ltd., Basel, Switzerland). After col-
lecting blood samples by one of the researchers (G.D-
D.), testing was performed in two reference laboratories
affiliated to teaching hospitals which had accreditation
in the field of immunoassay analyses: in Szczecin (pilot
group) and in Wrocław (study group). Two weeks after
sampling the participants could call the investigators at
a dedicated phone line and obtain their results by stating
their code. The study received ethical approval from the
Dolnoslaskie Region Ethical Committee (1/DR/2013).
Statistical analysis
Data analysis used the STATISTICA (PL Version 7.1.,
StatSoft Inc., 2005) and R (R version 3.0.2) software [13].
Our primary outcome variable was HBV vaccination and
we aimed to identify variables associated with this out-
come. Univariate analysis assessed demographic character-
istics (age, gender, residency, literacy, socio-economic and
employment status), together with knowledge on HB,
undergoing surgery in the past, facility location (urban/
rural), and GP clinic associated with an outcome variable.
For categoric variables groups were compared using the
chi square and Fisher's exact tests, whilst the U Mann–
Whitney test was used for numeric variables. Variables
whose p-values at the univariate level were lesser than
0.25 were used to build a multivariable regression model
[14], with the help of R software [13]. Regression coeffi-
cient (beta) was used to assess a change in the model. Co-
efficients for binary variables are equal to the natural
logarithm of the odds ratio; OR = exp(beta) [15].
Results
Of the total 413 consecutive patients eligible (i.e. ≥ 27 years
old), 410 (99.3 %) consented to participate, 271 of them
(66.1 %) were females. The median age for the study
population was 56 years (range 27–85). Almost two thirds
(64.9 %; n = 266) of participants were from the urban
areas, 35.1 % (n = 144) from the rural areas. More than
one third of participants (37.1 %; n = 152) were high
school graduates, 28.3 % (n = 116) had vocational educa-
tion, 17.8 % (n = 73) had a university degree, 16.8 % (n = 69)
had primary education. There were 13.4 % (n = 55) partici-
pants who described their socioeconomic status as high,
69.5 % (n = 285) - as moderate, 17.1 % (n = 70) as low.
Almost a half of participants (47.1 %; n = 193) were
employed, 31.7 % (n = 130) retired, 12.0 % (n = 49) un-
employed. Most of the participants (81.7 %; n = 335)
were from health-care facilities located in urban areas,
18.3 % (n = 75) from facilities located in rural areas
(Table 1).
As presented in Table 1, overall, only slight differences
were observed between facilities regarding participant
characteristics; it refers to age and HBV knowledge. Par-
ticipants from the pilot group were significantly younger
(p < 0.0002) and less knowledgeable (p < 0.0001) than
those in the other GP clinics. Participants from the GP2-
urban clinic were significantly younger (p < 0.04) than
those in the other GP clinics. Participants from the GP3-
rural clinic were more knowledgeable (p < 0.03) than
those in the other GP clinics, the same refers to partici-
pants from the GP5-urban clinic (p < 0.04). There were
statistically significant differences in the proportions of
participants living in urban versus rural areas between
clinics (p < 0.0001 - p = 0.005 respectively), except the
pilot group in which such proportions did not differ
when compared to other GP clinics (p = 0.56). There
were not any statistically significant differences observed
in vaccine uptake by clinic.
As there is a free choice concerning the type of facility,
regardless the place of residence, a proportion (73/335;
21.8 %) of residents from the rural areas attended facil-
ities in the urban areas and vice versa - a proportion (4/
75; 5.3 %) of residents from the urban areas attended a
facility in the rural area.
HBV vaccine uptake
Figure 1 presents HBV vaccine uptake by number of
doses, time category since receiving most recent vaccine
dose, and vaccination schedule. More than a half of the
participants - 55.4 % (227/410; 95%CI:50.5-60.1 %) were
previously vaccinated against HBV; in those 11.5 % (26/
227; 95%CI:7.9-16.3 %) with 2 doses of vaccine, 66.1 %
(150/227; 95%CI:59.7-71.9 %) with 3 doses, 18.1 % (41/
227; 95%CI:13.6-23.6 %) with 4 doses, 4.4 % (10/227;
95%CI:2.4-7.9 %) did not remember the number of doses
taken.
From 227 participants, 9.7 % (n = 22) were vaccinated
against HBV 0–12 months ago, 19.4 % (n = 44) over 1
but less or equal to 5 years ago, 33.0 % (n = 75) over 5
but less or equal to 10 years ago, 33.5 % (n = 76) more
than 10 years ago, 4.4 % (n = 10) did not remember and
their vaccination card was missing (Fig. 1). HBV vaccin-
ation by numbers of doses received versus time category
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since receiving most recent vaccine dose is presented in
Table 2.
Most of the participants (71.4 %; 162/227) were vacci-
nated with the use of 0-1-6 regimen, 15.0 % (34/227) with
a 0-1-6 regimen plus a booster dose, 1.3 % (3/227) with a
0-1-2-12 regimen, 1.8 % (4/227) with a 0-7-21-12 regimen,
10.5 % (24/227) did not remember the schedule (Fig. 1).
Reasons for immunization
Participants gave reasons for immunization: 57.7 %
(n = 131) were immunized due to the recommenda-
tion of surgeons referring them for various procedures,
10.1 % (n = 23) due to media campaigns, 4.8 % (n = 11)
due to the recommendations of family doctors, 4.0 %
(n = 9) due to the recommendations of family/friends,
in 2.2 % (n = 5) of cases the decision was made due
to a travel to countries of high or intermediate HBV
endemicity, the rest (21.1 %; n = 48) was vaccinated
for other reasons. Among 131 participants immunized
preoperatively - 12 (9.2 %) took two doses of vaccine,
99 (75.6 %) – three doses, 16 (12.2 %) - four doses, 4
(3.1 %) did not give any information about the num-
ber of doses taken.
Factors associated with vaccination
Factors associated with positive HBV vaccination status
are presented in Table 3 (a bivariate analysis was carried
out). Regarding age, significantly less (p = 0.04) of those
under and equal to 50 years were immunised (73/148;
49.3 %) compared to those between 51 and 60 years of
age (77/123; 62.6 %). No significant differences (p = 0.36)
were found between immunisation rates in those older
than 60 years (77/139; 55.4 %) versus those under and
equal to 50 years (73/148; 49.3 %), nor between immun-
isation rates in those older than 60 years versus those
between 51 and 60 years old (77/123; 62.6 % vs 77/139;
55.4 %); p = 0.29.
Immunisation rates varied by participants’ literacy
with significantly lower rates observed in those with a
primary education level (82/185; 44.3 %) comparing
with high school graduates (95/152; 62.5 %); p = 0.001
and university graduates (50/73; 68.5 %), p = 0.0008.
Concerning residency, 58.6 % of those living in the
cities were immunized, compared to 49.3 % living in
the rural areas; p = 0.09.
Table 1 Participant characteristics by GP clinic. Zgorzelec county, Poland, 2013; n = 410
Variable GP clinic
GP1 (urban)* GP2 (urban) GP3 (rural) GP4 (urban) GP5 (urban)
n1 n2 %
n1
p** n1 n2 %
n1
p** n1 n2 %
n1
p** n1 n2 %
n1
p** n1 n2 %
n1
p**
Vaccination uptake (Yes/No) 60 47 56.1 1.0 50 27 64.9 0.06 46 29 61.3 0.25 34 41 45.3 0.07 37 39 48.7 0.25
Age (≤50/>50 years) 47 60 46.4 0.0002 32 45 41.6 0.04 24 51 32.0 0.18 26 49 34.7 0.71 19 57 25.0 0.0001
Gender (F/M) 79 28 73.8 0.06 47 30 61.0 0.35 51 24 68.0 0.79 49 26 65.3 0.89 45 31 59.2 0.18
Education (university/other) 15 92 14.0 0.19 18 59 23.4 0.10 14 61 18.7 0.92 11 64 14.7 0.43 15 61 19.7 0.66
Residency(urban/rural) 72 35 67.2 0.56 64 13 83.1 0.0002 4 71 5.3 <0.0001 66 9 88.0 <0.0001 60 16 78.9 0.005
Socio-economic status (high/
low-median)
11 96 10.3 0.32 14 63 18.2 0.19 11 64 14.7 0.71 8 67 10.7 0.57 11 65 14.5 0.71
Employment(yes/no) 46 61 43.0 0.32 43 34 55.8 0.10 32 43 42.7 0.44 41 34 54.7 0.16 31 45 40.8 0.25
Past surgery(yes/no) 65 26 60.7 1.0 58 19 75.3 0.40 55 20 73.3 0.67 52 23 69.3 0.77 50 26 65.8 0.26
HBV knowledge (high/low) 30 77 28.0 <0.0001 32 45 41.6 0.31 44 31 58.7 0.03 42 33 56.0 0.10 44 32 57.9 0.04
Total 107 77 75 75 76
*pilot group
**proportions in a selected GP clinic vs other GP clinics
Fig. 1 HBV vaccination uptake among GP clinics patients by number
of doses, time since the last dose and regimen. Zgorzelec county,
Poland, 2013 (n = 227)
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In those having surgery in the past, immunisation rates
were higher than those not having surgery (64.6 % vs
35.5 %), p < 0.0001.
The median knowledge score was 16 points. In
those more knowledgeable (knowledge level >75 %,
i.e. >16.5 points) - 61.5 % were vaccinated, signifi-
cantly more (p = 0.03) than among less knowledgeable
ones (50.0 %).
No significant differences were found between immun-
isation rates regarding gender (p = 0.18), socio-economic
(p = 0.14) and employment status (p = 0.74), as well as
facility location (p = 0.24).
A multivariable regression model revealed that living
in an urban area, and having surgery in the past were
each determinants of vaccinating for HBV (Table 4);
facility location (urban GP clinics: 4 and 5) was associ-
ated with greater odds of poor immunization.
Anti-HBc total in unvaccinated participants
Out of 183 unvaccinated patients, 7 (3.8 %) refused to give
blood. The prevalence of anti-HBc total among unvaccin-
ated participants was 13.6 % (24/176; 95%CI:9.3 %-19,5 %).
Out of 227 vaccinated patients, 33 (14.5 %) refused to
give blood. Anti-HBc prevalence in those who agreed
was 7.2 % (14/194; 95%CI:4.4 %-11.8 %), 6.3 % (6/95) in
vaccinated preoperatively and 8.1 % (8/99) in vaccinated
for other reasons.







Time category since receiving most recent vaccine dose
0-5months >5 months-1 year >1 year
n % n % n %
2 26 4 15.4 3 11.5 19 73.1
3 150 0 0 14 9.3 136 90.7
4 41 0 0 1 2.4 40 97.6
Total 217 4 1.8 18 8.3 195 89.9
Zgorzelec county, Poland, 2013
Table 3 Factors associated with positive vaccination status (bivariate analysis); univariable model results
Variable Vaccinated N % p








































118 192 61.5 0.03
109 218 50.0
Zgorzelec county, Poland, 2013 (n = 410)
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None of anti-HBc positive participants had the history
of clinical HB, none was aware of an infection.
Discussion
Overview of the results
This study contributes to the literature by discussing the
HBV vaccination uptake among adult patients attending
GP practices in the context of immunization determi-
nants and anti-HBc total presence.
The HBV vaccination coverage among adult patients in
this study was 55 %, almost one in five of those patients
took a booster. The coverage was not satisfactory, how-
ever, much higher than in the other countries. More than
a half were immunized due to the recommendations of
surgeons referring them for various surgical procedures.
Sadly, only one in twenty patients was immunized due to
the recommendations of a family doctor. Living in a city,
as well as having a surgery in the past were each associ-
ated with greater odds of being vaccinated. In unvaccin-
ated patients, one in seven presented the evidence of HBV
infection; more than 7 % of those vaccinated were anti-
HBc total positive.
HBV vaccination uptake
In Poland, HBV vaccination is offered by a range of
healthcare facilities, however primary healthcare settings
take the lead, mainly because of their universal access.
Therefore, the poor involvement of family doctors regard-
ing HBV immunization observed in this study causes con-
cern and should be a subject of deeper analysis. GPs seem
to neglect this very important issue and do not discuss the
benefits of HBV vaccination with their patients. It is note-
worthy that HCWs involvement has a correlation to the
completion of vaccinations [16–18]. However, for many
HCWs time may be a barrier to discuss immunization at
patient’s visit. In a national US study 56 % pediatricians
pointed at that reason [17]. On the other hand, patients
indicate they want their primary providers to personally
discuss the issue with them [18, 19]. As reported also by
others [16, 17, 20], as well as in our previous study [19],
media, friends or relatives do not play a role as credible
sources of information on vaccination.
The HBV vaccination rate among study participants is
similar to that observed in 2011 among patients of the
Family Doctor Office and Cardiology Clinic in the Polish
city of Katowice [21], and also that observed among
1652 adult surgical patients surveyed in our own previ-
ous study, in 2009 [11]; self-reported information was
used in both surveys. Of note, the HBV vaccination
coverage among surgical and gynecologic nurses from
Polish hospitals surveyed by us in 2010 was 100 % [22].
HBV vaccination coverage assessed by a nationwide
cross-sectional telephone survey in Germany in 2004,
was 30 % [20]. In a more recent study from Hong Kong
it was only 26 % among the local Chinese population
and 33 % among pregnant women [23, 24]. Vaccination
uptake was assessed through face-to-face questionnaire
surveys. Among randomly selected Chinese adult immi-
grants residing in Vancouver, Canada, the vaccination
uptake was 38 %; face-to-face interviews were conducted
to assess the immunisation rate [25]. Data of men who
participated in a nationwide interview survey in the Re-
public of Korea showed that only 33 % received all three
doses of HBV vaccine [26]. The number of doses of HBV
vaccine received was based on self-reported information.
Factors related to HBV immunization
Our results may be useful in developing strategies to in-
creasing HBV vaccination coverage in the adult population
not only in Poland, but also in other countries, by identify-
ing the vaccination predictors. Similarly to the results ob-
tained in our previous study [11], the place of residence
influenced the vaccination uptake. Participants coming
from rural areas may have limited or inconsistent access to
healthcare, or limited need for immunization, or their need
may go unrecognized by primary care personnel.
The rate at which participants completed the vac-
cination series increased as a function of age regard-
ing patients in their 50s who were significantly more
likely to receive HBV vaccination than were those
younger. However, studies from abroad showed that
age was inversely associated with adult vaccination
status [20, 24, 27], which reflects a quite opposite
trend than observed in the present study. The pos-
sible explanation of our findings may be that - simi-
larly to those observed in another Polish survey [11]
- more than a half of the patients immunized them-
selves before surgery. Therefore, the detected trend
Table 4 Logistic regression model: association of HBV
vaccination among primary care clinic patients with selected
variables (OR’s estimates, 95 % CIs of OR estimates)
Variable / category ORa 95 % CI
Age > 50 years 1.55 0.964-2.512
Gender 0.97 0.605-1.556
Education: university degree 1.95 0.978-4.021
Residence: town 2.11 1.170-3.858
Socio-economic status: high 1.34 0.664-2.894
Surgery in the past 2.73 1.697-4.433
Knowledge on HBV infection: high 1.55 0.983-2.444
Facility location: GP clinic 2 0.90 0.440-1.834
Facility location: GP clinic 3 1.18 0.540-2.567
Facility location: GP clinic 4 0.35 0.171-0.703
Facility location: GP clinic 5 0.40 0.194-0.812
aOdds ratio = vaccination ratio between the two categories tested
in each variable, controlling for other variables
Zgorzelec county, Poland, n = 410; 2013
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may reflect specific Polish HBV vaccination policies
and simply illustrate an increasing need for various
surgical procedures among older patients. Further
studies are needed to confirm this hypothesis.
A higher level of education was positively associated
with the HBV vaccine uptake in the univariate analysis,
but not in the logistic regression model, possibly due to
the relatively small sample size as well as interactions
between variables, e.g. between education and socioeco-
nomic status. Surveys showed that attainment of higher
levels of education had a positive effect on HBV vaccin-
ation coverage [26–28]. It has been proved that educa-
tional level is strongly correlated with the amount of
health information sought, including vaccination-related
issues [26]. It can influence health-communication be-
haviors [29] and the acquisition and integration of new
information [30].
More than a half of primary care patients in our study
had been immunized against HBV due to the recom-
mendations of surgeons, which influenced the overall
vaccination uptake. Furthermore, multilevel regression
analysis revealed that those having a history of any sur-
gery in the past had a greater odds of being immunized.
In addition, most of those completed a 3-dose vaccin-
ation course. Therefore, our findings show the effective-
ness of the preoperative HBV vaccination strategy and
support the rationale for HBV immunisation to surgical
patients admitted for elective procedures. It has been
suggested [31] that vaccination of newborns together
with other polices, targeting adults, should be imple-
mented autonomously, as they complement each other.
Preoperative immunisation policy seems to be a signifi-
cant component of preventive methods, which have an
impact on the decrease of HBV incidence rate in the
community.
The multivariable regression analysis revealed that pa-
tients from two specific GP clinics (both located in
urban areas) had lower odds of being immunized. It
might be influenced by education strategies experienced
by patients which were used by medical personnel in
terms of HBV vaccination. Such an association due to
organizational differences between different facilities and
vaccinators was reported by others [32–34]. Addition-
ally, in the previous study on determinants of self-paid
vaccinations in 0-5-year-old children from GP practices
in Poland we found that in the group of parents for
whom the high price of a vaccine was an important obs-
tacle in a child’s immunization, the strongest determin-
ant for vaccinating a child was the type of facility, which
emphases an inevitable role of primary care HCWs in
optimal vaccine uptake [19].
As proven by this study, HBV is still a public health
threat in Poland, with 14 % of unvaccinated patients and
7 % of those vaccinated presenting serological markers
of this infection. Of note, none of those was aware of
the condition, being a possible source of infection for
others.
However, as HBV core total antibody is a marker of
past or current infection, without additional tests it is
not possible to determine the year of infection for those
participants with evidence of anti-HBc total. Potentially,
some of these infections might occur prior to the intro-
duction of preoperative vaccination. According to the
data obtained by this sero-survey, anti-HBc prevalence
in the individuals vaccinated preoperatively was 6 %. It
could be possible that most of those participants were
infected with HBV before vaccination and were not
tested for the markers of a previous infection before the
immunisation procedure [9, 11, 22]. Of note, although
the preoperative immunisation policy in Poland required
HBsAg checking, it did not refer to anti-HBc. Another
explanation is that some participants were vaccinated
but did not respond. As the anti-HBs titer was not
checked after the vaccination course, they were not
aware of the fact they were in the non-responders group.
Since they were still vulnerable, they contracted an
infection.
Regarding HBV vaccine, the three-dosage regimen is
recommended for its effectiveness [1, 5, 35]. Those who
develop a protective antibody response are protected
from clinical disease and chronic infection. The cost of a
course of HBV vaccination for adults in Poland, al-
though entirely covered by patients, is relatively low
(around 50$ US). However, one in nine patients in the
present study received only two doses of vaccine. Sero-
protection rates approach 95 % among healthy adults
after receiving the complete course of HBV vaccination
[1, 5, 35], but decrease up to 87 % among those who re-
ceived two doses only [36, 37]. It puts forward the ne-
cessity of completing the three-dose vaccination course.
Nevertheless, it should be noted that, as presented in
Table 2, more than one fourth of those receiving two
doses 0–12 months previously might have been due to
receive a further dose of vaccine to complete their
course of vaccination.
Limitations
Our results may be not be generalizable to the other GP
practices located in other regions of the country, espe-
cially in towns of more than 40.000 inhabitants. Further
studies on national level would be of value. Secondly,
while we highlighted patients’ demographic, other fac-
tors might have also influenced vaccination coverage.
The strength of the study was due to the involvement of
patients from randomly selected primary care practices,
with an excellent response rate of 98 %. Moreover, HBV
immunization status was not only based on self-reports of
previous immunization but also on the results of
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vaccination cards and serology tests which are perceived
as reliable means of determining the vaccination status of
the participants.
Data relating to vaccination status could be collected
via face-to-face interview, via vaccination cards and via
anti-HBs serology. There are inconsistencies between
these data sets indicating vaccination, which should be
discussed. The limitation of the studies based on face-
to-face interview techniques is the reliability of reported
vaccination against HBV, which reportedly gives rise to
some inaccuracy [20] (subject to faulty recall); this could
lead to both: under- or overestimation of the results.
The cross-checking vaccination cards or GP records could
possibly be subject to incorrect completion, which could
lead to an underestimation of immunization coverage. Fi-
nally, assessments of vaccination status based on anti-HBs
test results could be biased by the possibility of prior HBV
infection and lead to overestimation.
Conclusions
HBV immunization coverage among adult patients in
Poland is not satisfactory, however, much higher than in
the other countries. Low HBV immunization coverage
among adult patients and the presence of serological
markers of HBV infection among both - those unvaccin-
ated and vaccinated, call for comprehensive preventative
measures against infection, including greater GP prac-
tices involvement. Although interventions should cover
the whole population, inhabitants living in the rural
areas should be a group of special interest.
The uptake of HBV vaccine is excellent among Polish
newborns and teenagers [38], however adults seem to be
a neglected group. Thus, vaccination strategies should
be more optimized, and should include additional health
promotion and education programs implemented on a
national scale. We find evidence that recommended pre-
operative immunization for HBV is efficient in increas-
ing the vaccination uptake. Hence, it should serve as a
supportive public health tool to limit the spread of the
epidemic, especially in those countries in which nosoco-
mial HBV transmission remains a common route.
To increase the uptake it may be necessary to develop
tailored approaches that take into account the factors
identified in this study. Family doctors play a marginal
role in HBV vaccination. Hence, future interventions
should be addressed especially to GPs, making them cru-
cial players in the battle against HBV. Primary care staff
should be aware of their importance in recommending
vaccination to those at risk of HBV infection. Patients
should be provided with adequate information, advice
and support to enhance vaccination coverage which, in
the long run, will help to develop herd immunity. The
presence of serological markers of HBV infection among
one in seven of unvaccinated study participants and
among 7 % of those vaccinated stress the need for com-
prehensive preventative measures on population level.
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